Details for Patent: 6,127,425
Summary for Patent: 6,127,425
| Title: | Oral liquid medicine solution |
| Abstract: | Found is a pharmaceutical preparation which provides Tamoxifen Citrate in a liquid dosage form, viz. as an oral solution. The finding is based on a solvent comprising the following components: (a) of from 10% to 20% by weight of ethanol, (b) of from 10% to 60% by weight of a glycol; and (c) water, optionally containing additives, in a volume percentage adding up to 100% by volume. A preferred additive is sorbitol. |
| Inventor(s): | Roger Edward Tully |
| Assignee: | Rosemont Group Ltd |
| Application Number: | US09/106,172 |
|
Patent Claim Types: see list of patent claims | Composition; Process; Delivery; Dosage form; |
Drugs Protected by US Patent 6,127,425
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,127,425
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 97201964 | Jun 27, 1997 | |
International Family Members for US Patent 6,127,425
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 214269 | ⤷ Start Trial | |||
| Germany | 69804169 | ⤷ Start Trial | |||
| Denmark | 0893121 | ⤷ Start Trial | |||
| European Patent Office | 0893121 | ⤷ Start Trial | |||
| Spain | 2174388 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
